Table of Content


1. Service Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations

2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Pharmacy Benefit Management Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Service (Specialty Pharmacy, Drug Formulatory Management, Benefit Plan Design and Consultation, Other Services)
5.2.2. By Business Model (Government Health Programs, Employer-Sponsored Programs, Health Insurance Management)
5.2.3. By End-user (Pharmacy Benefit Management Organization, Mail Order Pharmacies, Retail Pharmacies, Other End-Users)
5.2.4. By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa)
5.2.5. By Company (2023)
5.3. Market Map
5.3.1 By Service
5.3.2 By Business Model
5.3.3 By End-user
5.3.4 By Region

6. North America Pharmacy Benefit Management Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Service (Specialty Pharmacy, Drug Formulatory Management, Benefit Plan Design and Consultation, Other Services)
6.2.2. By Business Model (Government Health Programs, Employer-Sponsored Programs, Health Insurance Management)
6.2.3. By End-user (Pharmacy Benefit Management Organization, Mail Order Pharmacies, Retail Pharmacies, Other End-Users)
6.2.4. By Country
6.3. North America: Country Analysis
6.3.1. United States Pharmacy Benefit Management Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Service
6.3.1.2.2. By Business Model
6.3.1.2.3. By End-user
6.3.2. Canada Pharmacy Benefit Management Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Service
6.3.2.2.2. By Business Model
6.3.2.2.3. By End-user
6.3.3. Mexico Pharmacy Benefit Management Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Service
6.3.3.2.2. By Business Model
6.3.3.2.3. By End-user

7. Europe Pharmacy Benefit Management Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Service (Specialty Pharmacy, Drug Formulatory Management, Benefit Plan Design and Consultation, Other Services)
7.2.2. By Business Model (Government Health Programs, Employer-Sponsored Programs, Health Insurance Management)
7.2.3. By End-user (Pharmacy Benefit Management Organization, Mail Order Pharmacies, Retail Pharmacies, Other End-Users)
7.2.4. By Country
7.3. Europe: Country Analysis
7.3.1. France Pharmacy Benefit Management Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Service
7.3.1.2.2. By Business Model
7.3.1.2.3. By End-user
7.3.2. Germany Pharmacy Benefit Management Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Service
7.3.2.2.2. By Business Model
7.3.2.2.3. By End-user
7.3.3. United Kingdom Pharmacy Benefit Management Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Service
7.3.3.2.2. By Business Model
7.3.3.2.3. By End-user
7.3.4. Italy Pharmacy Benefit Management Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Service
7.3.4.2.2. By Business Model
7.3.4.2.3. By End-user
7.3.5. Spain Pharmacy Benefit Management Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Service
7.3.5.2.2. By Business Model
7.3.5.2.3. By End-user

8. Asia-Pacific Pharmacy Benefit Management Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Service (Specialty Pharmacy, Drug Formulatory Management, Benefit Plan Design and Consultation, Other Services)
8.2.2. By Business Model (Government Health Programs, Employer-Sponsored Programs, Health Insurance Management)
8.2.3. By End-user (Pharmacy Benefit Management Organization, Mail Order Pharmacies, Retail Pharmacies, Other End-Users)
8.2.4. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Pharmacy Benefit Management Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Service
8.3.1.2.2. By Business Model
8.3.1.2.3. By End-user
8.3.2. India Pharmacy Benefit Management Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Service
8.3.2.2.2. By Business Model
8.3.2.2.3. By End-user
8.3.3. Japan Pharmacy Benefit Management Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Service
8.3.3.2.2. By Business Model
8.3.3.2.3. By End-user
8.3.4. South Korea Pharmacy Benefit Management Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Service
8.3.4.2.2. By Business Model
8.3.4.2.3. By End-user
8.3.5. Australia Pharmacy Benefit Management Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Service
8.3.5.2.2. By Business Model
8.3.5.2.3. By End-user
9. South America Pharmacy Benefit Management Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Service (Specialty Pharmacy, Drug Formulatory Management, Benefit Plan Design and Consultation, Other Services)
9.2.2. By Business Model (Government Health Programs, Employer-Sponsored Programs, Health Insurance Management)
9.2.3. By End-user (Pharmacy Benefit Management Organization, Mail Order Pharmacies, Retail Pharmacies, Other End-Users)
9.2.4. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Pharmacy Benefit Management Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Service
9.3.1.2.2. By Business Model
9.3.1.2.3. By End-user
9.3.2. Argentina Pharmacy Benefit Management Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Service
9.3.2.2.2. By Business Model
9.3.2.2.3. By End-user
9.3.3. Colombia Pharmacy Benefit Management Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Service
9.3.3.2.2. By Business Model
9.3.3.2.3. By End-user

10. Middle East and Africa Pharmacy Benefit Management Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Service (Specialty Pharmacy, Drug Formulatory Management, Benefit Plan Design and Consultation, Other Services)
10.2.2. By Business Model (Government Health Programs, Employer-Sponsored Programs, Health Insurance Management)
10.2.3. By End-user (Pharmacy Benefit Management Organization, Mail Order Pharmacies, Retail Pharmacies, Other End-Users)
10.2.4. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Pharmacy Benefit Management Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Service
10.3.1.2.2. By Business Model
10.3.1.2.3. By End-user
10.3.2. Saudi Arabia Pharmacy Benefit Management Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Service
10.3.2.2.2. By Business Model
10.3.2.2.3. By End-user
10.3.3. UAE Pharmacy Benefit Management Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Service
10.3.3.2.2. By Business Model
10.3.3.2.3. By End-user

11. Market Dynamics
11.1. Drivers
11.2. Challenges

12. Market Trends & Developments
12.1. Recent Development
12.2. Mergers & Acquisitions
12.3. Product Launches

13. Global Pharmacy Benefit Management Market: SWOT Analysis

14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products

15. Competitive Landscape
15.1. Optum, Inc.
15.1.1. Business Overview
15.1.2. Product Offerings
15.1.3. Recent Developments
15.1.4. Financials (As Reported)
15.1.5. Key Personnel
15.1.6. SWOT Analysis
15.2. Centene Corporation (Envolve Health)
15.2.1. Business Overview
15.2.2. Product Offerings
15.2.3. Recent Developments
15.2.4. Financials (As Reported)
15.2.5. Key Personnel
15.2.6. SWOT Analysis
15.3. CVS Health
15.3.1. Business Overview
15.3.2. Product Offerings
15.3.3. Recent Developments
15.3.4. Financials (As Reported)
15.3.5. Key Personnel
15.3.6. SWOT Analysis
15.4. SS&C Technologies, Inc.
15.4.1. Business Overview
15.4.2. Product Offerings
15.4.3. Recent Developments
15.4.4. Financials (As Reported)
15.4.5. Key Personnel
15.4.6. SWOT Analysis
15.5. Anthem, Inc.
15.5.1. Business Overview
15.5.2. Product Offerings
15.5.3. Recent Developments
15.5.4. Financials (As Reported)
15.5.5. Key Personnel
15.5.6. SWOT Analysis
15.6. Elixir Rx Solutions, LLC
15.6.1. Business Overview
15.6.2. Product Offerings
15.6.3. Recent Developments
15.6.4. Financials (As Reported)
15.6.5. Key Personnel
15.6.6. SWOT Analysis
15.7. Express Scripts Holding Company
15.7.1. Business Overview
15.7.2. Product Offerings
15.7.3. Recent Developments
15.7.4. Financials (As Reported)
15.7.5. Key Personnel
15.7.6. SWOT Analysis
15.8. Benecard Services, LLC
15.8.1. Business Overview
15.8.2. Product Offerings
15.8.3. Recent Developments
15.8.4. Financials (As Reported)
15.8.5. Key Personnel
15.8.6. SWOT Analysis
15.9. CaptureRx
15.9.1. Business Overview
15.9.2. Product Offerings
15.9.3. Recent Developments
15.9.4. Financials (As Reported)
15.9.5. Key Personnel
15.9.6. SWOT Analysis
15.10. Change Healthcare
15.10.1. Business Overview
15.10.2. Product Offerings
15.10.3. Recent Developments
15.10.4. Financials (As Reported)
15.10.5. Key Personnel
15.10.6. SWOT Analysis

16. Strategic Recommendations